BIOCENTECH APS: Financial statements 2021
CVR: 25437470
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
BIOCENTECH APS (CVR 25437470) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -6,250 and a net result of DKK -7,474 compared with DKK -6,750 the year before. Equity in the 2021 report amounted to DKK 9,278. The solvency ratio was 11.5%.
- Gross Profit
- DKK -6,250
- Profit/Loss
- DKK -7,474
- Equity
- DKK 9,278
- Total Assets
- DKK 80,479
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -6 t. | -7 t. | 9 t. | - |
| 2020 | - | -6 t. | -7 t. | 17 t. | - |
| 2019 | - | -5 t. | -5 t. | 24 t. | - |
| 2018 | - | -8 t. | -7 t. | 28 t. | - |
| 2017 | - | -5 t. | -3 t. | 35 t. | - |
Official annual report
Find more companies like BIOCENTECH APS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
BIOCENTECH APS has published its annual report for 2020. Gross profit came to DKK -6,250, and the net result was DKK -6,750.
About BIOCENTECH APS
BIOCENTECH APS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Aleksander Nærvig. The company is owned by NÆRVIG GROUP ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,000 and a net result of DKK -14,669 compared with DKK -19,363 the year before. Equity in the 2025 report amounted to DKK -61,305.
